STAT3 Cancer Research Results

STAT3, Signal transducer and activator of transcription 3: Click to Expand ⟱
Source:
Type: Oncogene
Stat3 (Signal Transducer and Activator of Transcription 3) is a transcription factor that plays a crucial role in various cellular processes, including cell growth, survival, differentiation, and immune response.
Stat3 is frequently found to be constitutively activated in many types of cancers, including breast, prostate, lung, and head and neck cancers. (associated with poor prognosis and reduced survival.)

-STAT3 is typically activated by cytokines (such as IL-6) and growth factors binding to their respective receptors.
-Activated STAT3 upregulates the expression of genes that promote cell cycle progression (e.g., cyclin D1) and anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL).
Scientific Papers found: Click to Expand⟱
1165- PI,    Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells
- in-vitro, GC, TMK-1
p38↓, IL6↓, STAT3↓,
1254- PI,  VitC,    Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS–STAT3 pathway
- in-vivo, GC, NA
STAT3⇅, eff↑, ROS↑, Apoptosis↑,
2946- PL,    Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
- Review, Var, NA
ROS↑, GSH↓, DNAdam↑, ChemoSen↑, RadioS↑, BioEnh↑, selectivity↑, BioAv↓, eff↑, p‑Akt↓, mTOR↓, GSK‐3β↓, β-catenin/ZEB1↓, HK2↓, Glycolysis↓, Cyt‑c↑, Casp9↑, Casp3↑, Casp7↑, cl‑PARP↑, TrxR↓, ER Stress↑, ATF4↝, CHOP/DDIT3↑, Prx4↑, NF-kB↓, cycD1/CCND1↓, CDK4↓, CDK6↓, p‑RB1↓, RAS↓, cMyc↓, TumCCA↑, selectivity↑, STAT3↓, NRF2↑, HO-1↑, PTEN↑, P-gp/ABCB1↓, MDR1↓, MRP1/ABCC1↓, survivin↓, Twist↓, AP-1↓, Sp1/3/4↓, STAT1↓, STAT6↓, SOX4↑, XBP-1↑, P21↑, eff↑, Inflam↓, COX2/PTGS2↓, IL6↓, MMP9↓, TumMeta↓, TumCI↓, ICAM-1↓, CXCR4↓, VEGF↓, angioG↓, Half-Life↝, BioAv↑,
2948- PL,    The promising potential of piperlongumine as an emerging therapeutics for cancer
- Review, Var, NA
tumCV↓, TumCP↓, TumCI↓, angioG↓, EMT↓, TumMeta↓, *hepatoP↑, *lipid-P↓, *GSH↑, cardioP↑, CycB/CCNB1↓, cycD1/CCND1↓, CDK2↓, CDK1↓, CDK4↓, CDK6↓, PCNA↓, Akt↓, mTOR↓, Glycolysis↓, NF-kB↓, IKKα↓, JAK1↓, JAK2↓, STAT3↓, ERK↓, cFos↓, Slug↓, E-cadherin↑, TOP2↓, P53↑, P21↑, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, Casp8↑, p‑HER2/EBBR2↓, HO-1↑, NRF2↑, BIM↑, p‑FOXO3↓, Sp1/3/4↓, cMyc↓, EGFR↓, survivin↓, cMET↓, NQO1↑, SOD2↑, TrxR↓, MDM2↓, p‑eIF2α↑, ATF4↑, CHOP/DDIT3↑, MDA↑, Ki-67↓, MMP9↓, Twist↓, SOX2↓, Nanog↓, OCT4↓, N-cadherin↓, Vim↓, Snail↓, TumW↓, TumCG↓, HK2↓, RB1↓, IL6↓, IL8↓, SOD1↑, RadioS↑, ChemoSen↑, toxicity↓, Sp1/3/4↓, GSH↓, SOD↑,
2950- PL,    Overview of piperlongumine analogues and their therapeutic potential
- Review, Var, NA
AntiAg↑, neuroP↑, Inflam↓, NO↓, PGE2↓, MMP3↓, MMP13↓, TumCMig↓, TumCI↓, p38↑, JNK↑, NF-kB↑, ROS↑, FOXM1↓, TrxR1↓, GSH↓, Trx↓, cMyc↓, Casp3↑, Bcl-2↓, Mcl-1↓, STAT3↓, AR↓, DNAdam↑,
1938- PL,    Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation
- Study, PSA, NA - in-vivo, NA, NA
ROS↑, Apoptosis↑, MMP↓, TumCCA↑, DNAdam↑, STAT3↓, Akt↓, PCNA↓, Ki-67↓, cycD1/CCND1↓, Bcl-2↓, K17↓, HDAC↓, ROS↑, *IL1β↓, *IL6↓, *TNF-α↓, *IL17↓, *IL22↓,
5160- PLB,  VitK3,    Plumbagin, Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization
- in-vitro, Melanoma, U266
STAT3↓, cSrc↓, JAK1↓, JAK2↓, SHP1↑, cycD1/CCND1↓, Bcl-xL↓, VEGF↓, Casp3↑, cl‑PARP↑, TumCCA↑, ChemoSen↑,
5155- PTL,    Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
- in-vitro, Liver, HepG2 - in-vitro, Nor, MEF - in-vitro, Cerv, HeLa - in-vitro, BC, MDA-MB-453
JAK↓, ROS↑, TumCMig↓, TumCG↓, STAT3↓,
1238- PTS,    Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention
- in-vitro, GC, NA - in-vivo, NA, NA
TumCCA↑, TumCP↓, TumCMig↓, TumCI↓, TumVol↓, TumW↓, Weight∅, JAK2↓, STAT3↓,
5034- PTS,    Pterostilbene in Cancer Therapy
- Review, Var, NA
BioAv↓, Half-Life↓, iNOS↓, Apoptosis↑, STAT3↓, Akt↓, mTOR↓, NF-kB↓, NRF2↓, ChemoSen↑, BBB↑,
4692- PTS,    Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol
- in-vitro, Cerv, HeLa
TumCG↓, TumMeta↓, TumCCA↑, ROS↑, Apoptosis↑, MMP2↓, MMP9↓, CD133↓, OCT4↓, SOX2↓, Nanog↓, STAT3↓, CSCs↓,
4689- PTS,    Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol
- in-vitro, Cerv, HeLa
eff↑, TumCCA↑, ROS↑, MMP2↓, MMP9↓, CSCs↓, CD133↓, OCT4↓, SOX2↓, Nanog↓, STAT3↓, BioAv↑, TumCI↓, ROS↑, Apoptosis↑,
2408- PTS,    Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway
- in-vitro, ESCC, NA
TumCP↓, TumCMig↓, PKA↓, GlucoseCon↓, lactateProd↓, PKM2↓, STAT3↓, cMyc↓,
3357- QC,    The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes
- in-vitro, AML, HL-60 - NA, NA, U937
DNMT1↓, DNMT3A↓, HDAC↓, ac‑H3↑, ac‑H4↑, BAX↑, APAF1↑, BNIP3↑, STAT3↑,
3354- QC,    Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine
- Review, Var, NA
*ROS↓, *IronCh↓, *lipid-P↓, *GSH↑, *NRF2↑, TumCCA↑, ER Stress↑, P53↑, CDK2↓, cycA1/CCNA1↓, CycB/CCNB1↓, cycE/CCNE↓, cycD1/CCND1↓, PCNA↓, P21↑, p27/CDKN1B↑, PI3K↓, Akt↓, mTOR↓, STAT3↓, cFLIP↓, cMyc↓, survivin↓, DR5↓, *Inflam↓, *IL6↓, *IL8↓, COX2/PTGS2↓, 5LO↓, *cardioP↑, *FASN↓, *AntiAg↑, *MDA↓,
3361- QC,    Quercetin ameliorates testosterone secretion disorder by inhibiting endoplasmic reticulum stress through the miR-1306-5p/HSD17B7 axis in diabetic rats
- in-vivo, Nor, NA - in-vitro, NA, NA
*BG↓, *ROS↓, *SOD↑, *MDA↓, *ER Stress↓, *iNOS↓, *CHOP/DDIT3↓, *GRP78/BiP↓, *antiOx↓, *Inflam↓, *JAK2↑, *STAT3?,
3368- QC,    The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update
- Review, Var, NA
*Inflam↓, *antiOx↑, *AntiCan↑, Casp3↓, p‑Akt↓, p‑mTOR↓, p‑ERK↓, β-catenin/ZEB1↓, Hif1a↓, AntiAg↓, VEGFR2/KDR/Flk1↓, EMT↓, EGFR↓, MMP2↓, MMP↓, TumMeta↓, MMPs↓, Akt↓, Snail↓, N-cadherin↓, Vim↓, E-cadherin↑, STAT3↓, TGF-β↓, ROS↓, P53↑, BAX↑, PKCδ↓, PI3K↓, COX2/PTGS2↓, cFLIP↓, cycD1/CCND1↓, cMyc↓, IL6↓, IL10↓, Cyt‑c↑, TumCCA↑, DNMTs↓, HDAC↓, ac‑H3↑, ac‑H4↑, Diablo↑, Casp3↑, Casp9↑, PARP1↑, Synergy↑, PTEN↑, VEGF↓, NO↓, iNOS↓, ChemoSen↑, Synergy↑, Synergy↑, Synergy↑, uPA↓, CXCR4↓, CXCL12↓, CLDN2↓, CDK6↓, MMP9↓, TSP-1↑, Ki-67↓, PCNA↓, ROS↑, ER Stress↑,
3380- QC,    Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases
- Review, Var, NA - Review, Park, NA - Review, AD, NA
JAK↓, STAT↓, Inflam↓, NO↓, COX2/PTGS2↓, CRP↓, selectivity↑, *neuroP↑, STAT3↓, cycD1/CCND1↓, MMP2↓, STAT4↓, JAK2↓, TumCP↓, Diff↓, *Synergy↑, *IL6↓, *TNF-α↓, *IL1β↓, *Aβ↓,
3604- QC,    Quercetin enrich diet during the early-middle not middle-late stage of alzheimer’s disease ameliorates cognitive dysfunction
- in-vivo, AD, NA
*cognitive↑, *Aβ↓, *neuroP↑, *BACE/β-secretase↓, *p‑SMAD2↓, *p‑STAT3↓, *SPARC↓,
4686- QC,    Quercetin suppresses endometrial cancer stem cells via ERα-mediated inhibition of STAT3 signaling
- in-vitro, EC, EMN8 - in-vitro, EC, EMN21
CSCs↓, ALDH1A1↓, cMyc↓, Nanog↓, OCT4↓, STAT3↓, JAK2↓, STAT3↓, eff↑,
56- QC,    Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
- in-vitro, PC, PANC1 - in-vitro, PC, PATU-8988
EMT↓, MMPs↓, MMP2↓, MMP7↓, STAT3↓, TumCI↓, TumMeta↓, tumCV↓,
95- QC,    Quercetin, a natural dietary flavonoid, acts as a chemopreventive agent
- in-vitro, Pca, PC3
p‑ERK↓, p‑STAT3↓, p‑Akt↓, N-cadherin↓, Vim↓, cycD1/CCND1↓, Snail↓, Slug↓, Twist↓, PCNA↓, EGFR↓, chemoPv↑,
82- QC,  ATG,    Arctigenin in combination with quercetin synergistically enhances the anti-proliferative effect in prostate cancer cells
- in-vitro, Pca, LNCaP
AR↓, PI3K/Akt↓, miR-21↓, STAT3↓, BAD↓, PRAS40↓, GSK‐3β↓, PSA↓, NKX3.1↑, Bax:Bcl2↑, miR-19b↓, miR-148a↓, AMPKα↓, TumCP↓, chemoPv↑, TumCMig↓,
910- QC,    The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism
- Review, Var, NA
tumCV↓, Apoptosis↑, PI3k/Akt/mTOR↓, Wnt/(β-catenin)↓, MAPK↝, ERK↝, TumCCA↑, H2O2↑, ROS↑, TumAuto↑, MMPs↓, P53↑, Casp3↑, Hif1a↓, cFLIP↓, IL6↓, IL10↓, lactateProd↓, Glycolysis↓, PKM2↓, GLUT1↓, COX2/PTGS2↓, VEGF↓, OCR↓, ECAR↓, STAT3↓, MMP2↓, MMP9:TIMP1↓, mTOR↓,
923- QC,    Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health
- Review, Var, NA
ROS↑, GSH↓, Ca+2↝, MMP↓, Casp3↑, Casp8↑, Casp9↑, other↓, *ROS↓, *NRF2↑, HO-1↑, TumCCA↑, Inflam↓, STAT3↓, DR5↑, P450↓, MMPs↓, IFN-γ↓, IL6↓, COX2/PTGS2↓, IL8↓, iNOS↓, TNF-α↓, cl‑PARP↑, Apoptosis↑, P53↑, Sp1/3/4↓, survivin↓, TRAILR↑, Casp10↑, DFF45↑, TNFR 1↑, Fas↑, NF-kB↓, IKKα↓, cycD1/CCND1↓, Bcl-2↓, BAX↑, PI3K↓, Akt↓, E-cadherin↓, Vim↓, β-catenin/ZEB1↓, cMyc↓, EMT↓, MMP2↓, NOTCH1↓, MMP7↓, angioG↓, TSP-1↑, CSCs↓, XIAP↓, Snail↓, Slug↓, LEF1↓, P-gp/ABCB1↓, EGFR↓, GSK‐3β↓, mTOR↓, RAGE↓, HSP27↓, VEGF↓, TGF-β↓, COL1↓, COL3A1↓,
916- QC,    Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells
- Review, Ovarian, NA
COX2/PTGS2↓, CRP↓, ER Stress↑, Apoptosis↑, GRP78/BiP↑, CHOP/DDIT3↑, p‑STAT3↓, PI3K↓, Akt↓, mTOR↓, cMyc↓, cycD1/CCND1↓, cFLIP↓, IL6↓, IL10↓,
4657- RES,    Resveratrol, cancer and cancer stem cells: A review on past to future
- Review, Var, NA
CSCs↓, CD133↓, Shh↓, Twist↓, Snail↓, MMP2↓, MMP9↓, Smad1↓, CD44↓, ALDH1A1↓, OCT4↓, Nanog↓, STAT3↓, survivin↓, cycD1/CCND1↓, COX2/PTGS2↓, cMyc↓,
2687- RES,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, NA, NA - Review, AD, NA
NF-kB↓, P450↓, COX2/PTGS2↓, Hif1a↓, VEGF↓, *SIRT1↑, SIRT1↓, SIRT2↓, ChemoSen⇅, cardioP↑, *memory↑, *angioG↑, *neuroP↑, STAT3↓, CSCs↓, RadioS↑, Nestin↓, Nanog↓, TP53↑, P21↑, CXCR4↓, *BioAv↓, EMT↓, Vim↓, Slug↓, E-cadherin↑, AMPK↑, MDR1↓, DNAdam↑, TOP2↓, PTEN↑, Akt↓, Wnt↓, β-catenin/ZEB1↓, cMyc↓, MMP7↓, MALAT1↓, TCF↓, ALDH↓, CD44↓, Shh↓, IL6↓, VEGF↓, Synergy↑, HK2↓, ROS↑, MMP↓,
3076- RES,    Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
- Review, Var, NA
IL6↓, MMPs↓, MMP2↓, MMP9↓, BioAv↓, Half-Life↑, BioAv↑, Dose↝, angioG↓, IL10↓, VEGF↓, NF-kB↓, COX2/PTGS2↓, SIRT1↑, Wnt↓, cMyc↓, STAT3↓, PTEN↑, ROS↑, RadioS↑, Hif1a↓, E-cadherin↓, Vim↓, angioG↓,
3095- RES,    Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk
- in-vitro, BC, NA
TumCP↓, TumCMig↓, TumCI↓, cycD1/CCND1↓, cMyc↓, MMP2↓, MMP9↓, SOX2↓, Akt↓, STAT3↓, α-SMA↓,
3096- RES,    Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis
- in-vitro, Lung, A549 - in-vitro, Lung, H1299
TumCP↓, Apoptosis↑, Akt↓, mTOR↓, p38↑, MAPK↑, STAT3↓, ROS↑, SIRT1↑, SOX2↓,
3098- RES,    Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers
- Review, Var, NA
NOTCH2↓, Wnt↓, β-catenin/ZEB1↓, p‑SMAD2↓, p‑SMAD3↓, PTCH1↓, Smo↓, Gli1↓, E-cadherin↑, NOTCH⇅, TAC?, NKG2D↑, DR4↑, survivin↓, DR5↑, BAX↑, p27/CDKN1B↑, cycD1/CCND1↓, Bcl-2↓, STAT3↓, STAT5↓, JAK↓, DNAdam↑, γH2AX↑,
3072- RES,    Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
- in-vitro, GBM, LN229 - in-vitro, GBM, U87MG
tumCV↓, TumCP↓, TumCMig↓, Apoptosis↑, NLRP3↓, JAK2↓, STAT3↓, IL1β↓, IL18↓, IL6↓, TNF-α↓, Inflam↓,
3071- RES,    Resveratrol and Its Anticancer Effects
- Review, Var, NA
chemoPv↑, SIRT1↑, Hif1a↓, VEGF↓, STAT3↓, NF-kB↓, COX2/PTGS2↓, PI3K↓, mTOR↓, NRF2↑, NLRP3↓, H2O2↑, ROS↑, P53↑, PUMA↑, BAX↑,
3018- RosA,    Rosemary (Rosmarinus officinalis L.) polyphenols and inflammatory bowel diseases: Major phytochemicals, functional properties, and health effects
- Review, IBD, NA
*Inflam↓, *GutMicro↑, *antiOx↑, *NF-kB↓, *NLRP3↓, *STAT3↓, *NRF2↑,
3003- RosA,    Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases
- Review, Var, NA - Review, AD, NA - Review, Park, NA
*Inflam↓, *antiOx↑, *neuroP↑, *IL6↓, *IL1β↓, *NF-kB↓, *PGE2↓, *COX2/PTGS2↓, *MMP↑, *memory↑, *ROS↓, *Aβ↓, *HMGB1↓, TumCG↓, MARK4↓, Zeb1↓, MDM2↓, BNIP3↑, ASC↑, NLRP3↓, PI3K↓, Akt↓, Casp1↓, E-cadherin↑, STAT3↓, TLR4↓, MMP↓, ICAM-1↓, AMPK↓, IL6↑, MMP2↓, Warburg↓, Bcl-xL↓, Bcl-2↓, TumCCA↑, EMT↓, TumMeta↓, mTOR↓, HSP27↓, Casp3↑, GlucoseCon↓, lactateProd↓, VEGF↓, p‑p65↓, GIT1↓, FOXM1↓, cycD1/CCND1↓, CDK4↓, MMP9↓, HDAC2↓,
3036- RosA,    Anti-Warburg effect of rosmarinic acid via miR-155 in colorectal carcinoma cells
- in-vitro, CRC, HCT8 - in-vitro, CRC, HCT116 - in-vitro, CRC, LS174T
GlucoseCon↓, lactateProd↓, Hif1a↓, Inflam↓, miR-155↓, STAT3↓, Glycolysis↓, IL6↓, Warburg↓,
7951- RT,  BuckWS,    The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives
- Review, Nor, NA
*Dose↝, *BioAv↓, *BioAv↓, *BioAv↓, *BioAv↓, *BioAv↝, TumCP↓, Risk↓, *radioP↑, chemoPv↑, TumCCA↑, GSK‐3β↑, Wnt↓, β-catenin/ZEB1↓, ROS↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, PARP↑, Beclin-1/ATG6↑, ATG5↑, LC3II↑, DNMT1↓, P21↑, CDK1↑, CycB/CCNB1↓, TNF-α↑, VEGF↓, IL1β↓, NF-kB↓, AP-1↓, MYCN↓, AMPK↑, MAPK↓, PI3K↓, Akt↓, cMET↓, P-gp/ABCB1↓, MRP1/ABCC1↓, ABCG2↓, MMPs↓, TNF-α↓, iNOS↓, COX2/PTGS2↓, angioG↓, STAT3↓, *chemoP↑, *ROS↓, *MDA↓, *P53↓, *Casp3↓, *Casp9↓, *JNK↓, *TNF-α↓, *p38↓, *MAPK↓, GSH↓, ChemoSen↑, *hepatoP↑, *COX1↓, *COX2/PTGS2↓, *15-LOX/ALOX15↓, RenoP↑, *toxicity↓,
4903- Sal,    Salinomycin: A new paradigm in cancer therapy
- Review, Var, NA
TumCG↓, ATP↓, CSCs↓, ROS↑, Casp↑, MMP↓, selectivity↑, OXPHOS↓, STAT3↓, P53↑, γH2AX↑, cycD1/CCND1↓, TumCCA↑, DNAdam↑, ChemoSen↑,
1210- SANG,    Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer
- in-vitro, BC, NA
EphB4↓, Hif1a↓, STAT3↓, MAPK↓, ERK↓,
1208- SANG,    Sanguinarine induces apoptosis in osteosarcoma by attenuating the binding of STAT3 to the single-stranded DNA-binding protein 1 (SSBP1) promoter region
- in-vitro, OS, NA
SSBP1↑, mtDam↑, Apoptosis↑, JAK↓, STAT3↓, PI3k/Akt/mTOR↓, ROS↑, MMP↓,
3656- SFN,    Chronic diseases, inflammation, and spices: how are they linked?
- Review, AD, NA
*AntiCan↑, *cardioP↑, *NRF2↑, *Inflam↓, *NF-kB↓, *STAT3↓, *ERK↓, *MAPK↓, AP-1↑, Bcl-2↓, Casp3↑, Casp9↑,
8778- SFN,    Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells
- in-vitro, Pca, DU145 - in-vitro, Pca, LNCaP
tumCV↓, IL6↓, STAT3↓, Dose↝, JAK2↓, Bcl-2↓, cycD1/CCND1↓, survivin↓, DNAdam↑, chemoPv↑,
1464- SFN,    d,l-Sulforaphane Induces ROS-Dependent Apoptosis in Human Gliomablastoma Cells by Inactivating STAT3 Signaling Pathway
- in-vitro, GBM, NA
Apoptosis↑, Casp3↑, BAX↑, Bcl-2↓, ROS↑, p‑STAT3↓, JAK2↓, eff↓,
3314- SIL,    Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review
- Review, Nor, NA
*antiOx↑, *hepatoP↑, *Half-Life↑, *ROS↓, *GSH↑, *hepatoP↑, *lipid-P↓, *TNF-α↓, *IFN-γ↓, *IL2↓, *IL4↓, *NF-kB↓, *iNOS↓, *OATPs↓, *OCT4↓, *Inflam↓, *PGE2↓, MMPs↓, VEGF↓, angioG↓, STAT3↓, *ALAT↓, *AST↓, Dose↝,
3301- SIL,    Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid
- Review, Var, NA
Inflam↓, TumCCA↑, Apoptosis↓, TumMeta↓, TumCG↓, angioG↓, chemoP↑, radioP↑, p‑ERK↓, p‑p38↓, p‑JNK↓, P53↑, Bcl-2↓, Bcl-xL↓, TGF-β↓, MMP2↓, MMP9↓, E-cadherin↑, Wnt↓, Vim↓, VEGF↓, IL6↓, STAT3↓, *ROS↓, IL1β↓, PGE2↓, CDK1↓, CycB/CCNB1↓, survivin↓, Mcl-1↓, Casp3↑, Casp9↑, cMyc↓, COX2/PTGS2↓, Hif1a↓, CXCR4↓, CSCs↓, EMT↓, N-cadherin↓, PCNA↓, cycD1/CCND1↓, ROS↑, Synergy↑, Synergy↑, Synergy↑, HER2/EBBR2↓,
3295- SIL,    Hepatoprotective effect of silymarin
- Review, Var, NA
*hepatoP↑, *ROS↓, *GSH↑, *BioAv↝, ERK↓, NF-kB↓, STAT3↓, COX2/PTGS2↓, Inflam↓, IronCh↑, lipid-P↓, ALAT↓, AST↓, TNF-α↓, *α-SMA↓, *SOD↑,
3293- SIL,    Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
- Review, Var, NA
hepatoP↑, TumMeta↓, Inflam↓, chemoP↑, radioP↑, Half-Life↝, *GSTs↑, p‑JNK↑, BAX↑, p‑p38↑, cl‑PARP↑, Bcl-2↓, p‑ERK↓, TumVol↓, Synergy↑, TumCCA↑, STAT3↓, Mcl-1↓, survivin↓, Bcl-xL↓, Casp3↑, Casp9↑, eff↑, CXCR4↓, Dose↝,
3289- SIL,    Silymarin: a promising modulator of apoptosis and survival signaling in cancer
- Review, Var, NA
*BioAv↝, *BioAv↓, Fas↑, FasL↑, FADD↑, pro‑Casp8↑, Apoptosis↑, DR5↑, Bcl-2↑, BAX↑, Casp3↑, PI3K↓, FOXM1↓, p‑mTOR↓, p‑P70S6K↓, Hif1a↓, Akt↑, angioG↓, STAT3↓, NF-kB↓, lipid-P↓, Synergy↑, CDK1↓, survivin↓, CycB/CCNB1↓, Mcl-1↓, Casp9↑, AP-1↓, BioAv↑,
3282- SIL,    Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions
- Review, Var, NA
hepatoP↑, AntiCan↑, TumCMig↓, Hif1a↓, selectivity↑, toxicity∅, *antiOx↑, *Inflam↓, TumCCA↑, P21↑, CDK4↓, NF-kB↓, ERK↓, PSA↓, TumCG↓, p27/CDKN1B↑, COX2/PTGS2↓, IL1↓, VEGF↓, IGFBP3↑, AR↓, STAT3↓, Telomerase↓, Cyt‑c↑, Casp↑, eff↝, HDAC↓, HATs↑, Zeb1↓, E-cadherin↑, miR-203↑, NHE1↓, MMP2↓, MMP9↓, PGE2↓, Vim↓, Wnt↓, angioG↓, VEGF↓, *TIMP1↓, EMT↓, TGF-β↓, CD44↓, EGFR↓, PDGF↓, *IL8↓, SREBP1/SREBF1↓, MMP↓, ATP↓, uPA↓, PD-L1↓, NOTCH↓, *SIRT1↑, SIRT1↓, CA↓, Ca+2↑, chemoP↑, cardioP↑, Dose↝, Half-Life↝, BioAv↓, BioAv↓, BioAv↓, toxicity↝, Half-Life↓, ROS↓, FAK↓,

Showing Research Papers: 351 to 400 of 428
Prev Page 8 of 9 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 428

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 9,   Catalase↓, 7,   Catalase↑, 4,   Copper↓, 1,   Fenton↑, 2,   GPx↓, 2,   GPx↑, 4,   GPx1↓, 1,   GPx4↓, 7,   GSH↓, 22,   GSH↑, 2,   GSR↓, 2,   GSR↑, 2,   GSTs↓, 1,   H2O2↑, 3,   HO-1↓, 4,   HO-1↑, 12,   HO-2↓, 1,   Iron↓, 1,   Iron↑, 4,   Iron↝, 1,   i-Iron↑, 1,   Keap1↑, 2,   lipid-P?, 1,   lipid-P↓, 3,   lipid-P↑, 11,   MDA↓, 2,   MDA↑, 6,   MPO↓, 1,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NOX4↑, 1,   NQO1↓, 1,   NQO1↑, 4,   NRF2↓, 22,   NRF2↑, 14,   NRF2↝, 1,   p‑NRF2↓, 1,   Prx↓, 1,   Prx3↑, 1,   Prx4↑, 1,   ox-PrxI↑, 1,   PrxII↓, 2,   ROS↓, 19,   ROS↑, 185,   ROS⇅, 7,   ROS∅, 2,   i-ROS↑, 1,   mt-ROS↑, 5,   SOD↓, 6,   SOD↑, 4,   SOD1↓, 1,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 1,   TAC?, 1,   TBARS↑, 1,   Trx↓, 2,   Trx1↑, 1,   TrxR↓, 7,   TrxR1↓, 2,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 6,   CDC25↓, 5,   compI↓, 2,   compII↓, 1,   compIV↓, 1,   compV↓, 1,   ETC↓, 2,   ETC↑, 1,   HSP60/HSPD1↓, 1,   mitResp↓, 7,   MKK7↓, 1,   mtDam↑, 17,   OCR↓, 8,   OXPHOS↓, 6,   SIRT3↓, 2,   SIRT3↑, 2,   SSBP1↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 4,   ACC↑, 1,   ACLY↓, 1,   ALAT↓, 4,   ALAT↝, 1,   ALDOA↓, 1,   AMPK↓, 2,   AMPK↑, 25,   AMPK↝, 1,   ATP↓, 14,   mt-ATP↓, 1,   BMAL1↝, 1,   CAIX/CA9↑, 1,   ECAR↓, 2,   ECAR↝, 1,   ENO1↓, 1,   FABP4↓, 1,   FAO↓, 1,   FAO↑, 1,   FASN↓, 4,   G6PD↓, 1,   GLO-I↓, 2,   GLS↓, 1,   glucose↓, 4,   GlucoseCon↓, 13,   GlucoseCon↑, 1,   glut↓, 1,   GlutMet↑, 1,   Glycolysis↓, 29,   GSK‐3β↓, 9,   GSK‐3β↑, 4,   p‑GSK‐3β↓, 5,   HK2↓, 16,   HMG-CoA↓, 1,   HSD17B4↓, 1,   lactateProd↓, 16,   lactateProd↑, 1,   LAR↓, 1,   LDHA↓, 8,   LDL↓, 1,   MCT4↓, 1,   NADH:NAD↓, 1,   NADPH↓, 1,   NADPH↑, 2,   PCK1↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 5,   p‑PDK1 / PDPK1↓, 1,   PDK3↑, 1,   PFK↓, 1,   PFK1↓, 1,   PKM2↓, 14,   PKM2↑, 1,   p‑PKM2↓, 1,   PLA2↓, 1,   PPP↓, 1,   Pyruv↓, 1,   p‑S6↓, 1,   SCD1↓, 2,   SIRT1↓, 7,   SIRT1↑, 7,   SIRT2↓, 2,   SREBF2↓, 1,   SREBP1/SREBF1↓, 1,   SREBP2↓, 1,   TCA↓, 1,   TCA↑, 2,   TS↓, 1,   Warburg↓, 6,  

Cell Death(tgid=5) ⓘ

AIF↑, 8,   APAF1↑, 4,   Apoptosis?, 2,   Apoptosis↓, 4,   Apoptosis↑, 157,   mt-Apoptosis↑, 3,   ASC↓, 1,   ASC↑, 1,   ASK1↑, 1,   BAD↓, 2,   BAD↑, 4,   Bak↑, 4,   BAX↓, 4,   BAX↑, 82,   BAX↝, 1,   BAX∅, 1,   Bax:Bcl2↑, 19,   Bcl-2↓, 105,   Bcl-2↑, 6,   Bcl-2∅, 1,   Bcl-xL↓, 41,   Bcl-xL∅, 1,   BID↓, 2,   BID↑, 3,   BIM↑, 5,   BNIP3↑, 3,   Casp↑, 26,   Casp↝, 1,   cl‑Casp↑, 2,   Casp1↓, 2,   Casp10↑, 1,   Casp12↑, 2,   Casp3?, 1,   Casp3↓, 2,   Casp3↑, 106,   cl‑Casp3↑, 15,   proCasp3↓, 1,   proCasp3↑, 1,   Casp7?, 1,   Casp7↑, 12,   cl‑Casp7↑, 2,   Casp8↓, 1,   Casp8↑, 22,   cl‑Casp8↑, 3,   pro‑Casp8↑, 1,   Casp9?, 1,   Casp9↑, 63,   cl‑Casp9↑, 6,   proCasp9↓, 1,   cFLIP↓, 9,   Cyt‑c↑, 44,   mt-Cyt‑c↓, 1,   Diablo↑, 5,   DR5↓, 1,   DR5↑, 22,   FADD↑, 3,   Fas↓, 1,   Fas↑, 15,   FasL↑, 3,   Ferroptosis↑, 12,   GranB/GZMB↑, 1,   GranB/GZMB↝, 1,   HEY1↓, 1,   IAP1↓, 8,   IAP2/BIRC3↓, 5,   ICAD↓, 1,   iNOS↓, 13,   iNOS↑, 1,   Mcl-1↓, 27,   Mcl-1↑, 2,   MDM2↓, 8,   p‑MDM2↓, 1,   MOMP↓, 1,   MOMP↑, 2,   Necroptosis↑, 1,   necrosis↑, 2,   NOXA↑, 3,   p38↓, 5,   p38↑, 16,   p‑p38↓, 3,   p‑p38↑, 6,   Perforin↑, 1,   Perforin↝, 1,   PUMA↑, 4,   Pyro↑, 1,   survivin↓, 67,   TNFR 1↑, 1,   TRAIL↑, 3,   TRAILR↑, 1,   TumCD?, 1,   TumCD↑, 12,   XIAP?, 1,   XIAP↓, 25,   XIAP↑, 1,   YAP/TEAD↓, 3,   YAP/TEAD↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 115,   Akt↑, 4,   Akt↝, 1,   p‑Akt↓, 31,   AMPKα↓, 1,   AMPKα↑, 1,   Brk/PTK6↓, 1,   CaMKII ↓, 2,   p‑CaMKII ↓, 1,   CIP2A↓, 1,   CK2↓, 4,   cMET↓, 6,   p‑cMET↑, 1,   cSrc↓, 8,   DDIT4↑, 1,   EF-1α↓, 1,   EGFR↓, 36,   EGFR↑, 1,   p‑EGFR↓, 3,   EphB4↓, 1,   ERK↓, 42,   ERK↑, 6,   ERK↝, 2,   p‑ERK↓, 18,   FGFR1↓, 2,   FGFR2↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 6,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 2,   HGF/c-Met↝, 1,   Hippo↓, 1,   IGF-1R↓, 6,   IGFR↓, 2,   IKKα↓, 7,   p‑IKKα↓, 1,   IR↓, 2,   IκB↑, 1,   JAK↓, 18,   JAK↝, 1,   p‑JAK↓, 1,   JAK1?, 1,   JAK1↓, 18,   JAK1↑, 2,   p‑JAK1↓, 3,   JAK2↓, 54,   p‑JAK2↓, 9,   p‑JAK3↓, 2,   JNK↓, 2,   JNK↑, 21,   p‑JNK↓, 1,   p‑JNK↑, 3,   LIFR/CD118↓, 1,   LIMK1↓, 1,   MAPK↓, 20,   MAPK↑, 15,   MAPK↝, 1,   p‑MAPK↓, 2,   p‑MAPK↑, 1,   MARK4↓, 1,   MEK↓, 5,   MKK4↓, 1,   mTOR↓, 73,   mTOR↝, 1,   p‑mTOR↓, 10,   mTORC2↓, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   P90RSK↓, 2,   p‑P90RSK↑, 1,   PAK↓, 1,   PDGFR-BB↓, 1,   PDGFR-BB↑, 1,   p‑PDGFR-BB↓, 1,   PI3K↓, 76,   PI3K↑, 3,   PI3K↝, 1,   p‑PI3K↓, 3,   PI3K/Akt↓, 4,   PI3k/Akt/mTOR↓, 2,   PIAS-3↑, 1,   PKA↓, 2,   PKCδ↓, 4,   PP2A↑, 1,   PRAS40↓, 1,   PTEN↓, 1,   PTEN↑, 26,   PTPN6↑, 2,   Raf↓, 3,   e-Raf↓, 1,   c-Raf↓, 1,   RAS↓, 8,   RAS↑, 1,   RET↓, 1,   p‑S6K↓, 1,   SHP1↓, 1,   SHP1↑, 7,   Sp1/3/4↓, 14,   Src↓, 5,   p‑Src↓, 1,   c-Src↓, 1,   STAT↓, 5,   p‑STAT2↓, 1,   STAT3↓, 321,   STAT3↑, 13,   STAT3⇅, 1,   STAT3↝, 3,   p‑STAT3↓, 74,   p‑STAT3↑, 4,   i-STAT3↓, 1,   mt-STAT3↓, 1,   STAT4↓, 2,   STAT4↑, 1,   STAT5↓, 8,   p‑STAT5↓, 1,   STAT6↓, 2,   p‑STAT6↓, 1,   STK11/LKB1↑, 1,   TK1↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 1,   ATF4↑, 4,   ATF4↝, 1,   CBP↓, 1,   cJun↓, 3,   cJun↑, 3,   cMyc↓, 50,   DNMT1↓, 9,   DNMT3A↓, 2,   DNMTs↓, 4,   EZH2↓, 2,   FOXM1↓, 6,   FOXO↓, 1,   FOXO↑, 1,   FOXO1↓, 1,   FOXO1↑, 1,   FOXO3↓, 3,   FOXO3↑, 5,   p‑FOXO3↓, 1,   FOXO4↓, 1,   FOXO4↑, 1,   GATA3↓, 1,   GATA3↑, 1,   H3↓, 1,   H3↑, 2,   p‑H3↓, 2,   ac‑H3↑, 2,   H4↓, 1,   H4↑, 1,   ac‑H4↑, 2,   HATs↓, 5,   HATs↑, 2,   HDAC↓, 18,   HDAC1↓, 3,   HDAC10↓, 1,   HDAC2↓, 3,   HDAC3↓, 3,   HDAC4↓, 1,   HDAC8↓, 3,   HES1↓, 1,   IRF1↑, 1,   JPT1/HN1↓, 1,   LINC01116↓, 1,   miR-107↑, 1,   miR-10b-5p↓, 1,   miR-134↑, 1,   miR-139-5p↑, 1,   miR-148a↓, 1,   miR-148a↑, 1,   miR-149↑, 1,   miR-155↓, 3,   miR-182-5p↓, 1,   miR-19b↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 1,   miR-21↓, 7,   miR-218↑, 1,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 1,   miR-29b↓, 1,   miR-301a-3p↓, 1,   miR-340↓, 1,   miR-34a↓, 2,   miR-34a↑, 2,   miR-422a↑, 1,   miR-592↑, 1,   Myc↓, 6,   MYCN↓, 1,   n-MYC↓, 1,   NDRG1↑, 1,   NNMT↓, 1,   OCT4↓, 13,   other↓, 3,   other↑, 1,   other↝, 5,   PAX2↓, 1,   PCAF↓, 1,   SOX2↓, 12,   SOX4↓, 2,   SOX4↑, 1,   SOX9?, 1,   SOX9↓, 1,   SUV39H↓, 2,   TFE3↑, 1,   tumCV↓, 49,   UTF1↑, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 18,   cl‑CHOP/DDIT3↑, 1,   eIF2α↓, 2,   eIF2α↑, 2,   p‑eIF2α↑, 5,   ER Stress↑, 31,   Erlin1↑, 1,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 8,   HSP27↓, 3,   HSP70/HSPA5↓, 2,   HSP70/HSPA5↑, 1,   HSP90↓, 15,   PERK↑, 4,   p‑PERK↑, 1,   Proteasome↓, 1,   UPR↑, 5,   XBP-1↓, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 4,   ATG7↑, 2,   Beclin-1/ATG6↓, 3,   Beclin-1/ATG6↑, 11,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3B-II↑, 1,   LC3II↓, 2,   LC3II↑, 9,   LC3s↑, 1,   MitoP↓, 1,   p62↓, 7,   SESN2↑, 2,   TumAuto↑, 24,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   BRCA1↓, 2,   BRCA1↑, 1,   BRCA2↑, 1,   DFF45↑, 1,   DNAdam↓, 2,   DNAdam↑, 37,   DNArepair↓, 2,   DNArepair↑, 1,   hTERT/TERT↓, 9,   NKX3.1↑, 1,   p16↑, 3,   P53?, 1,   P53↓, 3,   P53↑, 65,   P53↝, 2,   p‑P53↓, 1,   i-P53↓, 1,   PARP↓, 1,   PARP↑, 15,   cl‑PARP↑, 58,   proPARP↓, 1,   PARP1↑, 3,   cl‑PARP1↑, 1,   PCNA↓, 23,   SIRT6↓, 2,   SIRT6↑, 1,   Telomerase↓, 9,   TOP1↓, 7,   TOP2↓, 4,   TOP2↑, 1,   TP53↓, 1,   TP53↑, 2,   UHRF1↓, 1,   γH2AX↓, 1,   γH2AX↑, 6,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 14,   CDK1↑, 1,   p‑CDK1↓, 1,   CDK2↓, 28,   CDK4↓, 32,   CDK4↑, 1,   CDK6↓, 11,   CDK6↑, 1,   CDK8↓, 2,   CDKN1C/p57↑, 1,   CHK1↓, 4,   CHK1↑, 1,   Chk2↓, 3,   Chk2↑, 1,   cycA1/CCNA1↓, 7,   cycA1/CCNA1↑, 2,   CycB/CCNB1↓, 21,   CycB/CCNB1↑, 2,   cycD1/CCND1↓, 91,   cycD1/CCND1↑, 1,   CycD3↓, 3,   cycE/CCNE↓, 15,   cycE1↓, 1,   E2Fs↓, 4,   E2Fs↑, 1,   GADD45A↑, 1,   Ki-67↓, 26,   P21?, 1,   P21↓, 4,   P21↑, 46,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 20,   RB1↓, 1,   RB1↑, 1,   p‑RB1↓, 6,   TumCCA↓, 4,   TumCCA↑, 150,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 4,   ALDH1A1↓, 3,   Axin2↑, 1,   BMPs↑, 1,   CD133↓, 10,   CD24↓, 1,   CD34↓, 2,   cFos↓, 5,   cFos↑, 1,   CSCs↓, 42,   CSCs↑, 1,   CSCsMark↓, 1,   Diff↓, 2,   Diff↑, 1,   EIF4E↓, 2,   FGF↓, 3,   Gli↓, 1,   Gli1↓, 5,   HH↓, 5,   HMGCR↓, 1,   IGF-1↓, 4,   IGFBP1↑, 1,   IGFBP3↑, 1,   IGFBP7↑, 1,   JAG1↓, 1,   Ki-67↓, 26,   Let-7↑, 3,   LRP6↓, 1,   MSCmark↓, 1,   mTORC1↓, 4,   p‑mTORC1↓, 1,   Nanog↓, 13,   Nestin↓, 5,   NOTCH↓, 19,   NOTCH⇅, 1,   NOTCH1↓, 12,   NOTCH1↑, 3,   NOTCH1↝, 1,   NOTCH2↓, 1,   NOTCH3↓, 2,   p300↓, 2,   Piezo1↑, 1,   PTCH1↓, 3,   SCF↓, 1,   Shh↓, 8,   Smo↓, 3,   STAT1↓, 3,   p‑STAT1↓, 1,   TumCG?, 2,   TumCG↓, 74,   TumCG↑, 3,   TumCP?, 2,   TumCP↓, 120,   TumCP↑, 2,   tyrosinase↓, 1,   Wnt↓, 37,   Wnt↑, 1,   Wnt/(β-catenin)↓, 6,  

Migration(tgid=13) ⓘ

AntiAg↓, 1,   AntiAg↑, 2,   AP-1↓, 14,   AP-1↑, 1,   AP-1↝, 1,   ATPase↓, 1,   AXL↓, 2,   CA↓, 2,   Ca+2↑, 16,   Ca+2↝, 2,   CAFs/TAFs↓, 1,   cal2↓, 1,   CD11b↓, 1,   Cdc42↓, 1,   Chl↑, 1,   COL1↓, 1,   COL3A1↓, 1,   DLC1↑, 1,   E-cadherin↓, 8,   E-cadherin↑, 37,   EM↑, 1,   EMT↓, 68,   EMT↑, 2,   FAK↓, 16,   FAK↑, 1,   p‑FAK↓, 4,   fascin↓, 1,   Fibronectin↓, 2,   GIT1↓, 1,   GLI2↓, 1,   ITGA2↓, 1,   ITGA5↓, 3,   ITGA6↓, 1,   ITGB1↓, 3,   ITGB3↓, 1,   ITGB4↓, 1,   KRAS↓, 2,   LAMs↓, 2,   LEF1↓, 2,   MALAT1↓, 2,   MET↓, 3,   p‑MET↓, 1,   MMP-10↓, 1,   MMP1↓, 1,   MMP13↓, 3,   MMP15↓, 1,   MMP16↓, 1,   MMP2?, 1,   MMP2↓, 82,   MMP2↑, 1,   MMP3↓, 4,   MMP7↓, 8,   MMP9?, 1,   MMP9↓, 90,   MMP9↑, 2,   MMP9:TIMP1↓, 1,   MMPs↓, 24,   MUC4↓, 1,   N-cadherin↓, 25,   PAK1↓, 2,   PDGF↓, 4,   Rac1↓, 1,   Rho↓, 5,   ROCK1↓, 3,   Sharpin↓, 1,   Slug↓, 12,   Smad1↓, 2,   Smad1↑, 1,   p‑SMAD2↓, 1,   SMAD3↓, 1,   p‑SMAD3↓, 1,   Snail?, 1,   Snail↓, 24,   TET1↑, 2,   TGF-β↓, 15,   TGF-β↑, 1,   TIMP1↓, 2,   TIMP1↑, 3,   TIMP2↓, 2,   TIMP2↑, 4,   TRIB3↑, 2,   TSP-1↑, 3,   TumCI↓, 73,   TumCI↑, 1,   TumCMig↓, 70,   TumCMig↑, 1,   TumMeta↓, 52,   TumMeta↑, 8,   Twist↓, 22,   Tyro3↓, 1,   uPA↓, 14,   uPAR↓, 1,   Vim↓, 31,   Vim↑, 1,   Zeb1↓, 10,   ZEB2↓, 2,   α-SMA↓, 3,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 52,   β-catenin/ZEB1↑, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 69,   angioG↑, 3,   CD31/PECAM-1↓, 4,   ECM/TCF↓, 1,   Endoglin↑, 1,   eNOS↑, 1,   HIF-1↓, 5,   Hif1a↓, 57,   Hif1a↝, 2,   Hypoxia↓, 1,   NO↓, 5,   NO↑, 3,   NO↝, 1,   PHDs↓, 1,   VCAM-1↓, 1,   VEGF↓, 109,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 15,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 7,   CLDN1↓, 4,   CLDN1↑, 1,   CLDN2↓, 2,   EPR↑, 3,   GLUT1↓, 10,   GLUT1↑, 1,   GLUT3↑, 1,   GLUT4↓, 3,   IBI↑, 1,   MMP?, 1,   MMP↓, 67,   MMP↑, 1,   MMP↝, 1,   MPT↑, 3,   NHE1↓, 2,   OCLN↑, 1,   TJ↑, 1,   TRPV1↑, 3,   ZO-1↑, 4,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC∅, 1,   CB2 / CNR2↓, 1,   CB2 / CNR2↑, 1,   CCR7↓, 1,   CD4+↓, 1,   CD4+↑, 2,   CD44↓, 10,   CD8+↑, 2,   COX1↓, 3,   COX2/PTGS2↓, 69,   COX2/PTGS2↑, 2,   CXCL1↓, 1,   CXCL12↓, 2,   CXCR2↓, 1,   CXCR4↓, 14,   CXCR4↑, 1,   DR4↑, 7,   FOXP3↓, 2,   Gal-3↓, 2,   HCAR1↓, 1,   HMGB1↓, 1,   ICAM-1↓, 6,   IFN-γ↓, 1,   IFN-γ↑, 1,   IL1↓, 4,   IL1↑, 1,   IL10↓, 8,   IL10↑, 1,   IL12↓, 2,   IL18↓, 2,   IL1α↓, 2,   IL1β↓, 11,   IL2↓, 2,   IL2↑, 4,   IL4↓, 2,   IL4↑, 2,   IL5↓, 1,   IL6↓, 64,   IL6↑, 1,   IL7↓, 1,   IL8↓, 10,   Imm↑, 6,   Imm↝, 2,   Inflam↓, 33,   M2 MC↓, 3,   pol-M2 MC↓, 1,   MCP1/CCL2↓, 4,   MCT1↓, 3,   MIP2↓, 2,   NF-kB↓, 130,   NF-kB↑, 4,   NF-kB↝, 1,   p‑NF-kB↓, 2,   p‑NF-kB↑, 1,   NK cell↑, 4,   NLRP3↓, 5,   NLRP3↑, 2,   p65↓, 8,   p‑p65↓, 2,   ac‑p65↓, 1,   ac‑p65↑, 1,   PD-1↓, 3,   PD-L1↓, 15,   PGE2↓, 15,   PSA↓, 4,   PSA∅, 1,   RAGE↓, 1,   RANTES↓, 1,   SOCS-3↓, 1,   SOCS-3↑, 2,   SOCS1↑, 1,   T-Cell↑, 2,   TCF↓, 1,   TCF7/TCF1↓, 1,   Th1 response↑, 1,   Th17↓, 1,   TLR2↓, 1,   TLR4↓, 3,   TNF-α↓, 32,   TNF-α↑, 4,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   pH↓, 1,   pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   ADAM10↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 1,   AR↓, 16,   AR↑, 1,   ER-α36↓, 2,   ER(estro)↓, 1,   GR↑, 1,   PPARα↓, 2,   PPARα↝, 1,   PPARγ↓, 2,   PPARγ↑, 8,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   BioAv↓, 35,   BioAv↑, 33,   BioAv↝, 7,   BioEnh↑, 3,   chemoR↓, 1,   ChemoSen↓, 1,   ChemoSen↑, 110,   ChemoSen⇅, 1,   CompStab↓, 3,   CompStab↝, 1,   CYP1A1↓, 1,   CYP1A1↑, 1,   CYP1B1↑, 1,   Dose?, 3,   Dose↓, 2,   Dose↑, 6,   Dose↝, 34,   Dose∅, 11,   eff?, 1,   eff↓, 28,   eff↑, 55,   eff↝, 6,   eff∅, 1,   GSTA1↑, 1,   Half-Life↓, 14,   Half-Life↑, 1,   Half-Life↝, 11,   MDR1↓, 5,   MRP1/ABCC1↓, 4,   NAT↓, 1,   P-gp/ABCB1↓, 13,   P-gp/ABCB1↝, 1,   P450↓, 2,   RadioS↑, 39,   selectivity↑, 46,   selectivity∅, 1,   Synergy↑, 81,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↑, 1,   ALAT↓, 4,   ALAT↝, 1,   ALP↓, 2,   ALP↝, 1,   AR↓, 16,   AR↑, 1,   ascitic↓, 2,   AST↓, 3,   AST↝, 1,   BRCA1↓, 2,   BRCA1↑, 1,   CEA↓, 1,   CRP↓, 2,   E6↓, 3,   E7↓, 3,   EGFR↓, 36,   EGFR↑, 1,   p‑EGFR↓, 3,   EZH2↓, 2,   FOXM1↓, 6,   HER2/EBBR2↓, 6,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 9,   IL6↓, 64,   IL6↑, 1,   KRAS↓, 2,   LDH↓, 5,   LDH↝, 1,   Myc↓, 6,   NSE↓, 1,   PD-L1↓, 15,   PSA↓, 4,   PSA∅, 1,   RAGE↓, 1,   TG/TAG↓, 1,   TP53↓, 1,   TP53↑, 2,   TRIB3↑, 2,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 29,   antiD↑, 1,   antiNeop↑, 5,   AntiTum↓, 1,   AntiTum↑, 8,   cachexia↓, 4,   cardioP↑, 9,   CardioT↑, 1,   chemoP↑, 19,   chemoPv↑, 17,   ChemoSideEff↓, 1,   cognitive↑, 1,   hepatoP↓, 1,   hepatoP↑, 6,   K17↓, 1,   neuroP↑, 7,   NKG2D↑, 1,   Obesity↓, 2,   OS↑, 7,   Pain↓, 2,   QoL↑, 4,   radioP↑, 6,   RenoP↑, 4,   Risk↓, 3,   Strength↑, 1,   toxicity↓, 15,   toxicity↑, 2,   toxicity⇅, 1,   toxicity↝, 7,   toxicity∅, 1,   TumVol↓, 21,   TumVol∅, 1,   TumW↓, 13,   TumW∅, 1,   Weight↑, 1,   Weight∅, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   Bacteria↓, 1,   GutMicro↑, 6,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 3,  
Total Targets: 982

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 3,   antiOx↑, 52,   ARE↑, 2,   Catalase↑, 29,   DUOX1↓, 1,   Fenton↓, 1,   GPx↑, 18,   GPx4↑, 1,   GSH↑, 28,   GSR↑, 1,   GSTs↑, 10,   H2O2↓, 2,   HDL↓, 1,   HDL↑, 1,   HNE↑, 1,   HO-1↑, 16,   i-Iron↓, 1,   Keap1↓, 2,   lipid-P↓, 17,   MDA↓, 22,   MPO↓, 4,   MPO↑, 1,   NOX↓, 1,   NOX2↓, 1,   NOX4↓, 3,   NQO1↑, 4,   NRF2?, 1,   NRF2↓, 2,   NRF2↑, 29,   Prx↑, 1,   RNS↓, 1,   ROS?, 3,   ROS↓, 67,   SOD↑, 36,   SOD1↑, 3,   SOD2↑, 2,   TAC↑, 2,   TBARS↓, 3,   TOS↓, 1,   uricA↓, 1,   VitE↓, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mtDam↓, 2,   PINK1↓, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   15-LOX/ALOX15↓, 1,   5LO↓, 1,   ACC↓, 1,   ALAT↓, 8,   AMPK↓, 1,   AMPK↑, 6,   ATP↓, 1,   ATP↑, 1,   Buty↑, 1,   CRM↑, 1,   FASN↓, 2,   GSK‐3β↓, 1,   H2S↑, 1,   LDL↓, 2,   lipidLev↓, 1,   NAD↓, 1,   NAD↑, 1,   NADPH↓, 2,   NADPH↑, 3,   PLA2↓, 1,   SCFAs↑, 1,   SIRT1↑, 5,   SREBP1/SREBF1↓, 2,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 4,   BAX↓, 3,   Bcl-2↓, 2,   Bcl-2↑, 3,   Bcl-xL↑, 1,   BNIP3↓, 1,   Casp1↓, 1,   Casp3?, 1,   Casp3↓, 7,   Casp9↓, 4,   Cyt‑c↓, 1,   Ferroptosis↓, 1,   GSDMD↓, 1,   iNOS↓, 13,   p38↓, 2,   p38↑, 1,   p‑p38↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 5,   Akt↑, 5,   Akt↝, 1,   p‑Akt↑, 1,   AKT1↓, 1,   EGFR↓, 1,   ERK↓, 2,   ERK↑, 1,   IKKα↑, 1,   IκB?, 1,   JAK↓, 2,   p‑JAK1↓, 1,   JAK2↓, 3,   JAK2↑, 4,   p‑JAK2↓, 2,   JNK↓, 2,   p‑JNK↓, 2,   LPAR1/EDG2↑, 1,   MAPK↓, 9,   MAPK↑, 1,   MAPK↝, 1,   mTOR↓, 1,   mTOR↑, 3,   PI3K↓, 3,   PI3K↑, 5,   PTEN↑, 1,   STAT↓, 1,   STAT3?, 1,   STAT3↓, 18,   STAT3↑, 6,   STAT3↝, 1,   p‑STAT3↓, 4,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   ATF4↓, 3,   HDAC2↓, 1,   HOTAIR↑, 1,   OCT4↓, 1,   other↑, 2,   other↝, 2,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 3,   p‑eIF2α↓, 1,   ER Stress↓, 4,   GRP78/BiP↓, 2,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 1,   IRE1↓, 1,   p‑PERK↓, 1,   UPR↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG7↓, 1,   autophagy↓, 1,   Beclin-1/ATG6↓, 3,   LC3B↓, 1,   LC3II↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   Ki-67↓, 2,   P21↓, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Ki-67↓, 2,   neuroG↑, 2,   p300↓, 1,   p‑STAT1↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 2,   AP-1↓, 1,   Ca+2↓, 1,   Ca+2↝, 1,   COL1↓, 1,   COL1↑, 1,   Fibrosis↓, 1,   MMP13↓, 1,   MMP2↓, 1,   MMP2↑, 1,   MMP3↓, 1,   MMP9↓, 4,   p‑Rac1↓, 1,   ROCK1↓, 1,   Sema3A/PlexinA1↑, 1,   p‑SMAD2↓, 1,   SPARC↓, 1,   TGF-β↓, 1,   TGF-β↑, 2,   TGF-β1↓, 1,   TIMP1↓, 1,   TregCell↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   TXNIP↓, 1,   α-SMA↓, 4,   α-SMA↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 2,   CD31/PECAM-1↓, 1,   eNOS↑, 1,   NO↓, 12,   NO↑, 3,   VCAM-1↓, 1,   VEGF↓, 1,   VEGF↑, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 5,   BBB∅, 2,   IBI↑, 1,   MMP↑, 4,   OATPs↓, 1,   TJ↑, 2,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 1,   CD8+↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 17,   Eos↓, 1,   FOXP3↑, 1,   HMGB1↓, 4,   ICAM-1↓, 3,   IFN-γ↓, 4,   IL1↓, 1,   IL10↓, 4,   IL10↑, 4,   IL17↓, 5,   IL18↓, 2,   IL1β↓, 23,   IL2↓, 3,   IL22↓, 3,   IL23↓, 1,   IL4↓, 3,   IL4↑, 1,   IL5↓, 2,   IL6↓, 25,   IL8↓, 5,   Imm↓, 1,   Imm↑, 1,   Imm⇅, 1,   Inflam↓, 65,   Inflam↑, 2,   M2 MC↑, 1,   MCP1/CCL2↓, 2,   NeuroI↓, 1,   NF-kB↓, 30,   NF-kB↑, 1,   NLRP3↓, 7,   NLRP3↑, 1,   PGE2↓, 12,   PGE2↑, 1,   PSA↓, 1,   RAGE↓, 2,   SOCS-3↓, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR2↓, 1,   TLR4↓, 3,   TNF-α↓, 33,   TNF-α↑, 1,   Treg lymp↝, 1,   β-HEX↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 3,   BDNF↓, 1,   BDNF↑, 1,   GABA↑, 1,   PSD95↑, 1,   SNAP25↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 9,   BACE/β-secretase↓, 2,   tau↓, 2,   p‑tau↓, 1,   XO↓, 1,   β-Amyloid↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AHR↓, 1,   DHT↓, 1,   GLP-1R↑, 1,   GR↑, 1,   PPARα↑, 1,   PPARγ↑, 1,   p‑PPARγ↓, 1,   testos↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 29,   BioAv↑, 13,   BioAv↝, 12,   BioEnh↑, 1,   Dose?, 1,   Dose↓, 1,   Dose↑, 3,   Dose↝, 9,   eff↑, 7,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↑, 1,   Half-Life↝, 9,   Half-Life∅, 1,   P-gp/ABCB1↓, 1,   P450↓, 1,   P450↑, 1,   Synergy↑, 5,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 8,   ALP↓, 1,   AST↓, 9,   BG↓, 1,   BloodF↑, 1,   BMD↑, 3,   BP↓, 2,   creat↓, 2,   CRP↓, 1,   EGFR↓, 1,   IL6↓, 25,   LDH↓, 2,   NOS2↓, 1,   PSA↓, 1,   RAGE↓, 2,   SpO2↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 1,   antiAll↑, 14,   AntiArt↑, 4,   AntiCan↓, 1,   AntiCan↑, 10,   AntiDiabetic↑, 7,   antiPs↑, 1,   AntiTum↓, 1,   AntiTum↑, 3,   cardioP↑, 18,   chemoP↑, 3,   chemoPv↑, 2,   cognitive↑, 9,   diuretic↑, 3,   hepatoP↑, 30,   Learn↑, 2,   memory↑, 10,   motorD↑, 1,   Mucositis↓, 2,   neuroP↑, 41,   Obesity↓, 2,   OS↑, 2,   radioP↑, 2,   RenoP↑, 6,   Stroke↓, 4,   toxicity↓, 16,   toxicity↑, 1,   toxicity↝, 5,   toxicity∅, 5,   Weight↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 5,   AntiFungal↓, 1,   AntiP↑, 1,   AntiViral↑, 10,   Bacteria↓, 8,   GutMicro↑, 9,   GutMicro↝, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 2,  
Total Targets: 340

Scientific Paper Hit Count for: STAT3, Signal transducer and activator of transcription 3
27 Curcumin
15 Thymoquinone
13 Cucurbitacin
13 Quercetin
12 Apigenin (mainly Parsley)
12 Luteolin
10 Resveratrol
9 EGCG (Epigallocatechin Gallate)
9 Baicalein
9 Capsaicin
9 Chrysin
9 Garcinol
9 Honokiol
8 Ashwagandha(Withaferin A)
8 Betulinic acid
8 Emodin
8 Ginkgetin
8 Silymarin (Milk Thistle) silibinin
7 Lycopene
6 Berberine
6 brusatol
6 Kaempferol
5 Artemisinin
5 Beta-Caryophyllene
5 Caffeic acid
5 Matrine
5 Pterostilbene
4 Cisplatin
4 Radiotherapy/Radiation
4 Berbamine
4 Sorafenib (brand name Nexavar)
4 Carnosic acid
4 Celastrol
4 Cynaropicrin
4 Ellagic acid
4 Fisetin
4 Formononetin
4 Sulforaphane (mainly Broccoli)
4 Ginger/6-Shogaol/Gingerol
4 HydroxyTyrosol
4 Isoliquiritigenin
4 Ivermectin
4 Magnolol
4 Morin
4 Niclosamide (Niclocide)
4 Piperine
4 Piperlongumine
3 Gemcitabine (Gemzar)
3 Melatonin
3 Chemotherapy
3 Boswellia (frankincense)
3 Propolis -bee glue
3 Magnetic Fields
3 chaetocin
3 Dandelion Root
3 Gambogic Acid
3 Paclitaxel/Taxol
3 isoorientin
3 lambertianic acid
3 Licorice
3 Methylsulfonylmethane
3 Nimbolide
3 Oleocanthal
3 Phenethyl isothiocyanate
3 Rosmarinic acid
3 Shikonin
3 Ursolic acid
2 Andrographis
2 Ascorbyl Palmitate
2 Arctigenin
2 Baicalin
2 Brucea javanica
2 borneol
2 Boron
2 Centella asiatica / Gotu kola → asiaticoside
2 Cinnamon
2 immunotherapy
2 methylseleninic acid
2 Fucoidan
2 Gallic acid
2 Genistein (soy isoflavone)
2 Geraniol
2 Indole-3-carbinol
2 Juglone
2 Lasiodin
2 Licochalcone A
2 Modified Citrus Pectin
2 Metformin
2 Vitamin C (Ascorbic Acid)
2 Sanguinarine
2 Vitamin K2
1 5-Hydroxytryptophan
1 Allicin (mainly Garlic)
1 Alpha-Lipoic-Acid
1 DTS(dibenzyl trisulphide) from Anamu
1 Anethole/trans-Anethole
1 Astaxanthin
1 Biochanin A
1 Atorvastatin
1 Bufalin/Huachansu
1 Brutieridin–Melitidin Mixture
1 Black Rice, Oryza sativa
1 Caffeic Acid Phenethyl Ester (CAPE)
1 Carvacrol
1 Trastuzumab
1 Hydroxycinnamic-acid
1 Crocetin
1 Carvone
1 Oxygen, Hyperbaric
1 CUSP9
1 Deguelin
1 D-limonene
1 Tetrahydroxystilbene glucoside
1 Ferulic acid
1 Ginkgolic acids
1 Ginseng
1 Hydrogen Gas
1 epipolythiodioxopiperazine / epipolythiopiperazine-2,5-dione
1 Hyperoside
1 Isobavachalcone
1 Inositol
1 isoflavones
1 isoquercitrin
1 L-Theanine
1 Lactoferrin/Talactoferrin
1 Lemongrass Extract/Citral
1 mebendazole
1 Moringa oleifera
1 doxorubicin
1 tamoxifen
1 Mushroom Chaga, Inonotus obliquus
1 Mushroom Shiitake, AHCC
1 Naringin
1 Oleuropein
1 Orlistat
1 Marjoram (Origanum majorana)
1 Plumbagin
1 VitK3,menadione
1 Parthenolide
1 Rutin
1 buckwheat sprouts
1 salinomycin
1 Urolithin
1 Usnic acid
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:373  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page